Familial high-density lipoprotein deficiency states and premature coronary heart disease

E. Schaefer, R. Santos, M. Tani, Peter M. Schaefer, B. Asztalos
{"title":"Familial high-density lipoprotein deficiency states and premature coronary heart disease","authors":"E. Schaefer, R. Santos, M. Tani, Peter M. Schaefer, B. Asztalos","doi":"10.4147/HTCD-110307","DOIUrl":null,"url":null,"abstract":"High-density lipoprotein cholesterol (HDL-C) values <40 mg/dL have been shown to be an independent risk factor for coronary heart disease (CHD). Rare genetic disorders associated with marked human HDL deficiency include apolipoprotein A-I (apoA-I) deficiency with undetectable plasma apoA-I, which can be due to defects within the APOA1 gene resulting in lack of apoA-I secretion. Such patients have marked HDL deficiency, normal levels of triglycerides (TGs), and low-density lipoprotein cholesterol (LDL-C), and they can have xanthomas and premature CHD. ApoA-I variants with amino acid substitutions, especially in the region of amino acid residues 50–93 and 170–178, have been associated with amyloidosis. Patients with homozygous Tangier disease have defective cellular cholesterol efflux due to mutations in the adenosine-5′-triphosphate (ATP)-binding cassette transporter A1, detectable plasma apoA-I levels, and only pre-β1 HDL in their plasma. They have decreased LDL-C levels and can develop neuropathy and premature CHD. Patients with lecithin:cholesterol acyltransferase deficiency have both pre-β1 and α4 HDL present in their plasma and develop corneal opacities, anemia, proteinuria, and kidney failure. HDL deficiency has been associated with hypertriglyceridemia, obesity, insulin resistance, and diabetes. Common familial disorders associated with premature CHD and low HDL are: (1) dyslipidemia, seen in 15% of families, (2) combined hyperlipidemia, seen in 14% of families, and (3) hypoalphalipoproteinemia, seen in 4% of families. A common feature of all these disorders associated with premature CHD is a marked deficiency of very large α1 HDL. Niacin is currently the most optimal treatment strategy to raise HDL-C and normalize the HDL particle profile in these patients. Hot Topics in Cardiometabolic Disorders Volume 2 • Issue 3 • Year 2011 © FBCommunication Modena (Italy) Cite this article as: Schaefer EJ, Santos RD, Tani M, Schaefer PM, Asztalos BF. Familial high-density lipoprotein deficiency states and premature coronary heart disease. Hot Topics Cardiomet Disord 2011;2(3):7-16. E-mail: ernst.schaefer@tufts.edu Hot Topics in Cardiometabolic Disorders 2011;3:7-16 Copyright © 2011 FBCommunication s.r.l. a socio unico Downloaded from www.hottopicsin.com As shown in Figure 2-upper panel pre-β1 HDL is a very small disk with two molecules of apoA-I forming a belt (in yellow) around approximately 16 molecules of phospholipid (in blue), with a diameter of about 5.6 nm and a molecular weight of about 70 kDa. This particle is converted to small α4 HDL, which is a small disk with 2 molecules of apoA-I, but has about 26 molecules of phospholipid, and about 12 molecules of free cholesterol (in green), with a diameter of about 7.4 nm, and a molecular weight of about 80 kDa. Figure 2-lower panel depicts a model of medium spherical α3 HDL with 2 molecules of apoA-I, 1 molecule of apoA-II, with phospholipid and free cholesterol on its surface, and cholesteryl ester (in green) and TG (in purple) in the HDL core with a diameter of about 8.0 nm. The large spherical α2 HDL contains 4 molecules of apoA-I; 2 molecules of apoA-II, phospholipid, and free cholesterol on its surface; and cholesteryl ester and TG in its core, with a diameter of about 9.2 nm (see Figure 2–lower panel). The α1 HDL is very large and spherical with 8 molecules of apoA-I, phospholipid, and free cholesterol on its surface, and cholesteryl ester and TG in the core of HDL with a diameter of about 11.0 nm (see Figure 2–lower panel) [19]. In collaboration with George Rothblat’s laboratory, the authors studied the roles of HDL particles in ABCA1-, ABCG1-, and scavenger receptor class B type 1 (SRB1) mediated lipid flux [20-23]. It has been documented that only the small precursor HDL (pre-β1) was able to remove lipids (phospholipid and free cholesterol) from cells via the ABCA1 pathway, and that the bidirectional cell-lipid flux via the SRB1 mechanism was mediated by the larger HDL","PeriodicalId":229022,"journal":{"name":"Hot Topics in Cardiometabolic Disorders","volume":"17 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hot Topics in Cardiometabolic Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4147/HTCD-110307","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

High-density lipoprotein cholesterol (HDL-C) values <40 mg/dL have been shown to be an independent risk factor for coronary heart disease (CHD). Rare genetic disorders associated with marked human HDL deficiency include apolipoprotein A-I (apoA-I) deficiency with undetectable plasma apoA-I, which can be due to defects within the APOA1 gene resulting in lack of apoA-I secretion. Such patients have marked HDL deficiency, normal levels of triglycerides (TGs), and low-density lipoprotein cholesterol (LDL-C), and they can have xanthomas and premature CHD. ApoA-I variants with amino acid substitutions, especially in the region of amino acid residues 50–93 and 170–178, have been associated with amyloidosis. Patients with homozygous Tangier disease have defective cellular cholesterol efflux due to mutations in the adenosine-5′-triphosphate (ATP)-binding cassette transporter A1, detectable plasma apoA-I levels, and only pre-β1 HDL in their plasma. They have decreased LDL-C levels and can develop neuropathy and premature CHD. Patients with lecithin:cholesterol acyltransferase deficiency have both pre-β1 and α4 HDL present in their plasma and develop corneal opacities, anemia, proteinuria, and kidney failure. HDL deficiency has been associated with hypertriglyceridemia, obesity, insulin resistance, and diabetes. Common familial disorders associated with premature CHD and low HDL are: (1) dyslipidemia, seen in 15% of families, (2) combined hyperlipidemia, seen in 14% of families, and (3) hypoalphalipoproteinemia, seen in 4% of families. A common feature of all these disorders associated with premature CHD is a marked deficiency of very large α1 HDL. Niacin is currently the most optimal treatment strategy to raise HDL-C and normalize the HDL particle profile in these patients. Hot Topics in Cardiometabolic Disorders Volume 2 • Issue 3 • Year 2011 © FBCommunication Modena (Italy) Cite this article as: Schaefer EJ, Santos RD, Tani M, Schaefer PM, Asztalos BF. Familial high-density lipoprotein deficiency states and premature coronary heart disease. Hot Topics Cardiomet Disord 2011;2(3):7-16. E-mail: ernst.schaefer@tufts.edu Hot Topics in Cardiometabolic Disorders 2011;3:7-16 Copyright © 2011 FBCommunication s.r.l. a socio unico Downloaded from www.hottopicsin.com As shown in Figure 2-upper panel pre-β1 HDL is a very small disk with two molecules of apoA-I forming a belt (in yellow) around approximately 16 molecules of phospholipid (in blue), with a diameter of about 5.6 nm and a molecular weight of about 70 kDa. This particle is converted to small α4 HDL, which is a small disk with 2 molecules of apoA-I, but has about 26 molecules of phospholipid, and about 12 molecules of free cholesterol (in green), with a diameter of about 7.4 nm, and a molecular weight of about 80 kDa. Figure 2-lower panel depicts a model of medium spherical α3 HDL with 2 molecules of apoA-I, 1 molecule of apoA-II, with phospholipid and free cholesterol on its surface, and cholesteryl ester (in green) and TG (in purple) in the HDL core with a diameter of about 8.0 nm. The large spherical α2 HDL contains 4 molecules of apoA-I; 2 molecules of apoA-II, phospholipid, and free cholesterol on its surface; and cholesteryl ester and TG in its core, with a diameter of about 9.2 nm (see Figure 2–lower panel). The α1 HDL is very large and spherical with 8 molecules of apoA-I, phospholipid, and free cholesterol on its surface, and cholesteryl ester and TG in the core of HDL with a diameter of about 11.0 nm (see Figure 2–lower panel) [19]. In collaboration with George Rothblat’s laboratory, the authors studied the roles of HDL particles in ABCA1-, ABCG1-, and scavenger receptor class B type 1 (SRB1) mediated lipid flux [20-23]. It has been documented that only the small precursor HDL (pre-β1) was able to remove lipids (phospholipid and free cholesterol) from cells via the ABCA1 pathway, and that the bidirectional cell-lipid flux via the SRB1 mechanism was mediated by the larger HDL
家族性高密度脂蛋白缺乏状态与早发冠心病
高密度脂蛋白胆固醇(HDL-C)值<40 mg/dL已被证明是冠心病(CHD)的独立危险因素。与显著的人类高密度脂蛋白缺乏相关的罕见遗传疾病包括载脂蛋白A-I (apoA-I)缺乏,血浆中无法检测到apoA-I,这可能是由于APOA1基因缺陷导致apoA-I分泌不足。这些患者有明显的高密度脂蛋白缺乏,正常水平的甘油三酯(tg)和低密度脂蛋白胆固醇(LDL-C),他们可能有黄斑瘤和早期冠心病。具有氨基酸替换的apoa - 1变异,特别是在氨基酸残基50-93和170-178区域,与淀粉样变性有关。纯合子丹吉尔病患者由于腺苷-5 ' -三磷酸(ATP)结合盒转运蛋白A1的突变,血浆apoA-I水平可检测,血浆中只有前β1 HDL存在缺陷。他们的LDL-C水平降低,并可能发展为神经病变和早期冠心病。卵磷脂:胆固醇酰基转移酶缺乏症患者血浆中存在-β1和α4前HDL,并发角膜混浊、贫血、蛋白尿和肾衰竭。高密度脂蛋白缺乏与高甘油三酯血症、肥胖、胰岛素抵抗和糖尿病有关。与早期冠心病和低HDL相关的常见家族性疾病有:(1)血脂异常,见于15%的家族;(2)合并高脂血症,见于14%的家族;(3)低脂蛋白血症,见于4%的家族。所有这些与早期冠心病相关的疾病的一个共同特征是α - 1高密度脂蛋白明显缺乏。在这些患者中,烟酸是目前提高HDL- c和使HDL颗粒谱正常化的最佳治疗策略。心脏代谢疾病热点话题第2卷•第3期•2011年©FBCommunication Modena(意大利)引用本文为:Schaefer EJ, Santos RD, Tani M, Schaefer PM, Asztalos BF。家族性高密度脂蛋白缺乏状态与早发冠心病。心内科疾病研究热点2011;2(3):7-16。版权所有©2011 FBCommunication s.r.l. a socio unico下载自www.hottopicsin.com如图2所示,pre-β1 HDL是一个非常小的圆盘,由两个apoA-I分子围绕大约16个磷脂分子(蓝色)形成一条带(黄色),直径约5.6 nm,分子量约70 kDa。该颗粒转化为小α4 HDL,是一个含有2分子apoA-I的小圆盘,但含有约26分子磷脂和约12分子游离胆固醇(绿色部分),直径约7.4 nm,分子量约80 kDa。图2-下面板为中等球形α3 HDL模型,含有2分子apoA-I和1分子apoA-II,其表面有磷脂和游离胆固醇,高密度脂蛋白核直径约8.0 nm为胆固醇酯(绿色)和TG(紫色)。大球形α2 HDL含有4个apoA-I分子;2分子apoA-II、磷脂和游离胆固醇在其表面;其核心为胆固醇酯和TG,直径约为9.2 nm(见图2 -下面板)。α - 1 HDL非常大,呈球形,表面有8个apoa - 1分子、磷脂分子和游离胆固醇分子,其核心为胆固醇酯和TG分子,直径约为11.0 nm(见图2 -下面板)[19]。作者与George Rothblat实验室合作,研究了HDL颗粒在ABCA1-、ABCG1-和清道夫受体B类1 (SRB1)介导的脂质通量中的作用[20-23]。已有文献表明,只有小前体HDL (pre-β1)能够通过ABCA1途径从细胞中去除脂质(磷脂和游离胆固醇),并且通过SRB1机制的双向细胞脂质通量是由较大的HDL介导的
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信